Chancellor M B, Bennett C, Simoneau A R, Finocchiaro M V, Kline C, Bennett J K, Foote J E, Green B G, Martin S H, Killoran R W, Crewalk J A, Rivas D A
Division of Urologic Surgery, University of Pittsburgh, Pennsylvania 15213, USA.
J Urol. 1999 Jun;161(6):1893-8.
In a prospective randomized multicenter trial we compared the treatment results of conventional external sphincterotomy with those of UroLume sphincteric stent prosthesis placement in men with spinal cord injury and external detrusor-sphincter dyssynergia.
We randomized 57 men with spinal cord injury in whom urodynamics verified external detrusor-sphincter dyssynergia into 2 groups to undergo either sphincter defeating procedure. We compared the primary urodynamic parameter of maximum detrusor pressure, and secondary urodynamic parameters of bladder capacity and post-void residual urine volume in men who underwent sphincterotomy or sphincteric stent placement. Parameters were measured preoperatively, and 3, 6, 12 and 24 months postoperatively. Patients completed questionnaires regarding voiding sensation and quality of life issues at each followup visit.
Demographic data of the 26 patients treated with sphincterotomy and the 31 treated with sphincteric stent placement were statistically similar. Preoperatively mean maximum detrusor pressure plus or minus standard deviation in sphincterotomy and stent cases was 98.3 +/- 27.6 and 95.7 +/- 27.7 cm. water, respectively (p = 0.73). At 12 months mean maximum detrusor pressure decreased to 48.9 +/- 16.4 and 52.6 +/- 31.6 cm. water in the sphincterotomy and stent groups, respectively (p = 0). Preoperatively mean bladder capacity in sphincterotomy and stent cases was 245 +/- 158 and 251 +/- 145 ml., respectively (p = 0.87). Bladder capacity did not change significantly in either treatment group throughout followup. Preoperatively mean post-void residual urine volume in the sphincterotomy and stent groups was 212 +/- 163 and 168 +/- 114 ml., respectively (p = 0.33). Residual urine volume decreased in each group at some but not all followup evaluations. The duration of hospitalization was greater for sphincterotomy than stenting (p = 0.036). Six stents required explantation.
The UroLume stent is as effective as conventional external sphincterotomy for treating external detrusor-sphincter dyssynergia. However, sphincteric stent placement is advantageous because it involves shorter hospitalization and is potentially reversible.
在一项前瞻性随机多中心试验中,我们比较了传统外括约肌切开术与UroLume括约肌支架假体置入术对脊髓损伤合并外逼尿肌-括约肌协同失调男性患者的治疗效果。
我们将57例经尿动力学证实存在外逼尿肌-括约肌协同失调的脊髓损伤男性患者随机分为两组,分别接受一种括约肌破坏手术。我们比较了接受括约肌切开术或括约肌支架置入术患者的主要尿动力学参数最大逼尿肌压力,以及次要尿动力学参数膀胱容量和排尿后残余尿量。在术前、术后3、6、12和24个月测量这些参数。患者在每次随访时完成关于排尿感觉和生活质量问题的问卷调查。
26例行括约肌切开术患者和31例行括约肌支架置入术患者的人口统计学数据在统计学上相似。术前,括约肌切开术组和支架置入术组的平均最大逼尿肌压力加减标准差分别为98.3±27.6和95.7±27.7 cm水柱(p = 0.73)。12个月时,括约肌切开术组和支架置入术组的平均最大逼尿肌压力分别降至48.9±16.4和52.6±31.6 cm水柱(p = 0)。术前,括约肌切开术组和支架置入术组的平均膀胱容量分别为245±158和251±145 ml(p = 0.87)。在整个随访过程中,两个治疗组的膀胱容量均无显著变化。术前,括约肌切开术组和支架置入术组的平均排尿后残余尿量分别为212±163和168±114 ml(p = 0.(此处原文疑似有误,应为0.33))。在一些但并非所有的随访评估中,每组的残余尿量均有所减少。括约肌切开术的住院时间比支架置入术长(p = 0.036)。有6个支架需要取出。
UroLume支架在治疗外逼尿肌-括约肌协同失调方面与传统外括约肌切开术效果相当。然而,括约肌支架置入术具有优势,因为它住院时间较短且可能具有可逆性。